FR2190453A1 - - Google Patents

Info

Publication number
FR2190453A1
FR2190453A1 FR7323456A FR7323456A FR2190453A1 FR 2190453 A1 FR2190453 A1 FR 2190453A1 FR 7323456 A FR7323456 A FR 7323456A FR 7323456 A FR7323456 A FR 7323456A FR 2190453 A1 FR2190453 A1 FR 2190453A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7323456A
Other languages
French (fr)
Other versions
FR2190453B1 (en:Method
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2190453A1 publication Critical patent/FR2190453A1/fr
Application granted granted Critical
Publication of FR2190453B1 publication Critical patent/FR2190453B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7323456A 1972-06-30 1973-06-27 Expired FR2190453B1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH984672 1972-06-30

Publications (2)

Publication Number Publication Date
FR2190453A1 true FR2190453A1 (en:Method) 1974-02-01
FR2190453B1 FR2190453B1 (en:Method) 1976-04-09

Family

ID=4356299

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7323456A Expired FR2190453B1 (en:Method) 1972-06-30 1973-06-27

Country Status (18)

Country Link
AT (1) AT338412B (en:Method)
AU (1) AU476456B2 (en:Method)
BE (1) BE801645A (en:Method)
CA (1) CA1015272A (en:Method)
DD (1) DD107592A5 (en:Method)
DE (1) DE2327636A1 (en:Method)
ES (1) ES416383A1 (en:Method)
FR (1) FR2190453B1 (en:Method)
GB (1) GB1369189A (en:Method)
HU (1) HU167292B (en:Method)
IE (1) IE37833B1 (en:Method)
IL (1) IL42317A (en:Method)
LU (1) LU67898A1 (en:Method)
NL (1) NL7308435A (en:Method)
PH (1) PH9584A (en:Method)
SE (1) SE407744B (en:Method)
SU (1) SU533323A3 (en:Method)
ZA (1) ZA733284B (en:Method)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
SE407744B (sv) 1979-04-23
ZA733284B (en) 1974-03-27
ES416383A1 (es) 1976-02-16
GB1369189A (en) 1974-10-02
AU476456B2 (en) 1976-09-23
NL7308435A (en:Method) 1974-01-02
AT338412B (de) 1977-08-25
IL42317A (en) 1976-04-30
SU533323A3 (ru) 1976-10-25
CA1015272A (en) 1977-08-09
LU67898A1 (en:Method) 1975-04-11
ATA574273A (de) 1976-12-15
IE37833B1 (en) 1977-10-26
IE37833L (en) 1973-12-30
FR2190453B1 (en:Method) 1976-04-09
DE2327636A1 (de) 1974-01-17
BE801645A (fr) 1974-01-02
DD107592A5 (en:Method) 1974-08-12
PH9584A (en) 1976-01-19
HU167292B (en:Method) 1975-09-27
AU5589773A (en) 1974-11-21
IL42317A0 (en) 1973-07-30

Similar Documents

Publication Publication Date Title
FR2199595A1 (en:Method)
FR2204788B1 (en:Method)
JPS5220927Y2 (en:Method)
JPS4976524A (en:Method)
JPS5112532B2 (en:Method)
FR2206216A1 (en:Method)
JPS5310293Y2 (en:Method)
JPS4936899U (en:Method)
JPS4890702A (en:Method)
JPS5029547Y2 (en:Method)
FR2190453B1 (en:Method)
CS172495B1 (en:Method)
JPS4898669A (en:Method)
AU4933872A (en:Method)
AU481250A (en:Method)
CH559264A5 (en:Method)
CH562404A5 (en:Method)
CH587961A5 (en:Method)
CH586716A5 (en:Method)
CH562023A5 (en:Method)
CH584676A5 (en:Method)
BG18165A1 (en:Method)
BG18280A1 (en:Method)
BG18528A1 (en:Method)
BG18655A1 (en:Method)

Legal Events

Date Code Title Description
ST Notification of lapse